KalVista Pharmaceuticals up 16%, offering prices of $160 million (NASDAQ:KALV)

KalVista Pharmaceuticals (NASDAQ: VEAL) has priced an underwritten public offering of approximately 7 million shares to the public at $15.25 per share and pre-funded warrants to purchase approximately 3.48 million shares in lieu of KalVista common stock for certain investors .

The gross proceeds

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *